STRATEOS SMARTLAB STUDIO
DEAD

Serial Number

90700877

Owner

Strateos, Inc.

Attorney

Stacey J. Watson, Esq.

Filing Date

May 10, 2021

Add to watchlist:

No watchlists yet
View on USPTO

STRATEOS SMARTLAB STUDIO Trademark

Serial Number: 90700877

STRATEOS SMARTLAB STUDIO is a trademark filed by Strateos, Inc. on May 10, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Strateos, Inc. (6 trademarks)

3565 Haven Avenue, Suite 3
Menlo Park, CA 94025

Entity Type: 03

Trademark Details

Filing Date

May 10, 2021

Registration Date

Not Registered

Goods & Services

Software as a service ("SAAS") featuring access to remote and on-demand automated cloud labs accessible from a web browser that enable users around the world to easily access and control drug discovery, cell and gene therapy and synthetic biology workflows; Workflows for designing laboratory experiments, for running laboratory experiments, generating data, for reviewing and analyzing laboratory and environmental data, and experiment results; Provide support to the pharmaceutical, biotechnology, healthcare, synthetic biology, agscience and medical device industries in the form of research services, biopharmaceutical development, biologic assay development, commercialization, preclinical research, clinical research, and pharmacovigilance; software as a service ("SAAS") featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment results; software as a service ("SAAS") featuring software for research and development of chemicals, pharmaceuticals, biologics, and vaccines, and cell and gene therapies; software as a service ("SAAS") for providing regulatory compliance documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits following experiments; conducting laboratory experiments on behalf of others; scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; toxicological testing services for pharmaceuticals, chemicals, biologics, vaccines, and cell and gene therapies; biopharmaceutical and synthetic biology research design and scientific testing services; custom assay development for chemicals, pharmaceuticals, biologics, vaccines, and cell and gene therapies; technological consultancy in the field of information technology; technological consultancy in the field of life sciences, drug discovery, synthetic biology software engineering, hardware engineering and laboratory automation

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 1, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 1, 2022 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 15, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 15, 2021 GNRT
NON-FINAL ACTION WRITTEN
Dec 15, 2021 CNRT
ASSIGNED TO EXAMINER
Nov 17, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 10, 2021 NWOS
NEW APPLICATION ENTERED
May 13, 2021 NWAP